Skip to Main Content

Lauren E. Cipriano

Associate Professor, Management Science

Associate Professor, Epidemiology and Biostatistics
Associate Professor, Department of Medicine
Deputy Editor, Medical Decision Making and Medical Decision Making Policy & Practice
Canada Research Chair in Healthcare Analytics, Management, and Policy

Lauren E. Cipriano

Contact Information

Download CV


  • Simulation
  • Public Policy
  • Health Care Management Science
  • Health Economics
  • Analytics
  • Pharmacoeconomics
  • Cost Effectiveness Analysis
  • Markov Models
  • Statistics
  • Biotechnology
  • Health Sector
  • Technology adoption
  • Spreadsheets & VBA
  • Health Policy Evaluation

Research Publications

  • To search for publications by a specific faculty member, select the database and then select the name from the Author drop down menu.

Lauren Cipriano is an Associate Professor in Management Science at the Ivey Business School where she is the Canada Research Chair in Healthcare Analytics, Management, and Policy. She holds cross appointments in the Department of Medicine and the Department of Epidemiology and Biostatistics at the Schulich School of Medicine & Dentistry at Western University.

Dr. Cipriano’s research expertise focuses on the application of statistics, decision analysis, economics, and operations research to health policy problems. She has specific expertise in the economic evaluation of clinical diagnostics and novel therapeutics, resource allocation, and infectious disease policy.

Dr. Cipriano has consulted for the World Health Organization, US Veterans Health Administration, US Centers for Medicare and Medicaid Services, the US Institute for Clinical and Economic Review, and the Canadian Agency for Drugs and Technologies in Health (CADTH). During the pandemic, Dr. Cipriano served on the Ontario COVID-19 Science Advisory Table’s Modelling Consensus Table.

Dr. Cipriano is an Investigator with the Toronto Health Economics and Technology Assessment (THETA) Collaborative and a Research Affiliate with the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH).  She sat on the Health Economics Methods Advisory Committee for the Canadian Agency for Drugs and Technologies in Health (CADTH) from 2019-2023 and was awarded CADTH’s Dr. Maurice McGregor Award for Health Technology Assessment in 2019.

Dr. Cipriano is the Deputy Editor of the journals Medical Decision Making and MDM Policy & Practice.

Dr. Cipriano received her MS in Statistics and PhD in Management Science and Engineering from Stanford University. She previously worked at the Institute for Technology Assessment at Massachusetts General Hospital.

Dr. Cipriano joined Ivey in 2013. At Ivey, Dr. Cipriano teaches undergraduate Decision Making with Analytics and graduate courses in Business Analytics and Statistics.


Recent Publications

Goldhaber-Fiebert JD, Cipriano LE. Pricing treatments cost-effectively when they have multiple indications: not just a simple threshold analysis.  Medical Decision Making. 2023 Oct-Nov;43(7-8):914-929. [link]

Cipriano LE, Haddara WMR, Zaric GS, Enns EA. Impact of university re-opening on total community COVID-19 burden. Plos One. 2021; 16(8):e0255782 [link]

Fairley M, Cipriano LE, Goldhaber-Fiebert JD.  Optimal allocation of research funds under a budget constraint.  Medical Decision Making. 2020; 40(6):797–814 [link]

Chehrazi N, Cipriano LE, Enns EA.  Dynamics of drug resistance: optimal control of an infectious disease. Operations Research.  2019; 67(3):619–650. [link]

Cipriano LE, Weber TA.  Population-level intervention and information-collection in dynamic healthcare policy. Health Care Management Science. 2018; 21(4):604–631. [link]

Cipriano LE, Goldhaber-Fiebert JD, Liu S, Weber TA.  Optimal information collection policies in a Markov decision process framework. Medical Decision Making. 2018; 38(7):797–809. [link]

Cipriano LE, Liu S, Shahzada KS, Holodniy M, Goldhaber-Fiebert JD.  Economically efficient hepatitis C virus treatment prioritization improves health outcomes. Medical Decision Making. 2018; 38(7): 849–865. [link]        

Cipriano LE, Zaric GS.  Cost-effectiveness of naloxone kits in secondary schools. Drug and Alcohol Dependence. 2018; 192:352–361. [link]

For a full list of publications, please see Google Scholar


  • Decision Making with Analytics (HBA)
  • Multivariable Statistics (PhD)
  • Business Statistics (MM-A, MSc)


  • B.Sc., Honors Biochemistry, Western University
  • HBA, Ivey Business School, Western University
  • M.S., Statistics, Stanford University
  • Ph.D., Management Science, Stanford University

Recent Refereed Articles

  • Hafeez, A.; Cipriano, L. E.; Kim, R. B.; Zaric, G. S.; Schwarz, U. I.; Sarma, S., 2024, "Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada", PharmacoEconomics, January 42(1): 69 - 90.
  • Goldhaber-Fiebert, J.; Cipriano, L. E., 2023, "Pricing Treatments Cost-Effectively when They Have Multiple Indications: Not Just a Simple Threshold Analysis", Medical Decision Making, October 43(7-8): 914 - 929.
  • Tran, C.; Cipriano, L. E.; Driman, D. K., 2023, "Impact of COVID-19-related health care disruptions on pathologic cancer staging during the first pandemic year: a retrospective cohort study from March 2018 to March 2021", CMAJ Open, May 11(3): E475 - E484.
  • Roseborough, A. D.; Saad, L.; Goodman, M.; Cipriano, L. E.; Hachinski, V. C.; Whitehead, S. N., 2023, "White matter hyperintensities and longitudinal cognitive decline in cognitively normal populations and across diagnostic categories: A meta‐analysis, systematic review, and recommendations for future study harmonization", Alzheimers & Dementia, January 19(1): 194 - 207.
  • Vilches, T. N.; Abdollahi, E.; Cipriano, L. E.; Haworth-Brockman, M.; Keynan, Y.; Sheffield, H.; Langley, J. M.; Moghadas, S. M., 2022, "Impact of non-pharmaceutical interventions and vaccination on COVID-19 outbreaks in Nunavut, Canada: a Canadian Immunization Research Network (CIRN) study", Bmc Public Health, December 22(1): 1042 - 1042.
  • Tarride, J-E.; Cheung, M.; Hanna, T. P.; Cipriano, L. E.; Regier, D. A.; Hey, S. P.; Chan, K. K. W.; Mittmann, N., 2022, "Platform, Basket, and Umbrella Trial Designs: Issues Around Health Technology Assessment of Novel Therapeutics", Canadian Journal of Health Technologies, July 2(7)
  • Avan, A.; Hachinski, V.; Aamodt, A. H.; Alessi, C.; Ali, S.; Alladi, S.; Andersen, R.; Anderson, K. K.; Avan, A.; Azarpazhooh, M. R., et al., 2022, "Brain health: Key to health, productivity, and well-being", Alzheimer's and Dementia, July 18(7): 1396 - 1407.
  • Cipriano, L. E.; Haddara, W. M. R.; Zaric, G. S.; Enns, E. A., 2021, "Impact of University Re-opening on Total Community COVID-19 Burden", PLOS ONE, August 16(8): e0255782 - e0255782.
  • Avan, A.; Amiri, A.; Mokhber, N.; Erfanian, M.; Cipriano, L. E.; Stranges, S.; Shojaeianbabaei, G.; Abootalebi, S.; Azarpazhooh, M. R., 2021, "Association of lewy bodies, hippocampal sclerosis and amyloid angiopathy with dementia in community-dwelling elderly: A systematic review and meta-analysis", Journal of Clinical Neuroscience, August 90: 124 - 131.
  • Vilches, T. N.; Nourbakhsh, S.; Zhang, K.; Juden-Kelly, L.; Cipriano, L. E.; Langley, J. M.; Sah, P.; Galvani, A. P.; Moghadas, S. M., 2021, "Multifaceted strategies for the Control of COVID-19 Outbreaks in Long-Term Care Facilities in Ontario, Canada", Preventive Medicine, July 148: 106564 - 106564.
  • Yarmol-Matusiak, E. A.; Cipriano, L. E.; Stranges, S., 2021, "A comparison of COVID-19 epidemiological indicators in Sweden, Norway, Denmark, and Finland", Scandinavian Journal of Public Health, February 49(1): 69 - 78.
  • Bansback, N. J.; Barbosa, C.; Barocas, J.; Bayoumi, A. M.; Behrends, C.; Chhatwal, J.; Cipriano, L. E.; Coffin, P.; Goldhaber-Fiebert, J. D.; Hoch, J., et al., 2021, "How simulation modeling can support the public health response to the opioid crisis in North America: Setting priorities and assessing value", International Journal of Drug Policy, February 88: 102726 - 102726.
  • Formosa, E. A.; Grainger, L. A.; Roseborough, A. D.; Sereda, A. M.; Cipriano, L. E., 2020, "A Survey of Canadian, Student-Run Campus Emergency Medical Response Teams", The Journal of Collegiate Emergency Medical Services, December 3(2): 11 - 19.
  • Fairley, M.; Cipriano, L. E.; Goldhaber-Fiebert, J. D., 2020, "Optimal Allocation of Research Funds under a Budget Constraint", Medical Decision Making, August 40(6): 797 - 814.
  • Roseborough, A. D.; Langdon, K. D.; Hammond, R.; Cipriano, L. E.; Pasternak, S. H.; Whitehead, S. N.; Khan, A. R., 2020, "Post-mortem 7 Tesla MRI detection of white matter hyperintensities: A multidisciplinary voxel-wise comparison of imaging and histological correlates", NeuroImage: Clinical, July 27

For more publications please see our Research Database

Honours & Awards

  • Dr. Maurice McGregor Award, Canadian Agency for Drugs and Technologies in Health, 2019
  • Seth Bonder Foundation Research Award, 2012
  • Lee B. Lusted Student Prize Award for outstanding presentations of research in Applied Health Economics, Annual Meeting of the Society for Medical Decision Making, 2012
  • Course Assistant Award, Department of Management Science & Engineering, Stanford University, 2012
  • Seth Bonder Scholarship for Applied Operations Research in Health Services, INFORMS, 2011
  • Award for Outstanding Short Course, Annual Meeting of the Society for Medical Decision Making, 2010, 2011
  • Centennial Teaching Assistant Award, Stanford University, 2011


  • Member, Modelling Consensus Table, Ontario COVID-19 Science Advisory Table. August 2021 – September 2022
  • Member, Health Economics Advisory Council, Canadian Agency for Drugs and Technologies in Health (CADTH). 2019 – 2023
  • Member, Canadian Foundation for Healthcare Improvement, Return on Investment Working Group, 2018–2019
  • Evidence review team, Guideline Developing Group focusing on Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C virus Infection. World Health Organization (WHO). Geneva, Switzerland. 2017
  • Visiting Researcher, Management of Technology and Entrepreneurship Institute (MTEI), École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland (Spring 2012)
  • Research Scientist. Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA (2006-2008)
  • Queuing Project Manager, Ontario Joint Replacement Registry, London Health Sciences Centre, London, ON (2004-2006)

Connect with Ivey Business School